glp-1 drugs stocks Which Drug to Watch in 2025 GLP-1 Costs Explained: Managing Coverage
Description
Understanding Semaglutide What are Ozempic and Wegovy
This analysis estimates clinical eligibility and use of GLP-1 drugs among adults under age 65 in the private and employer-sponsored insurance (ESI) markets using the 2023 National Health Interview Survey (NHIS) and Merative MarketScan commercial claims data
doi:10.5812/ijem.13249 Wilding John P.H., Batterham Rachel L., Calanna Salvatore, et al
If any comment is reported and identified as inappropriate content by OAE staff, the comment will be removed without notice
